K-numberK252235
Device namePVAD IQ Software
ApplicantUltrasight , Ltd.
Product codeQIH
Device classClass II
Decision dateDec 18, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

PVAD IQ Software is a machine learning-based ultrasound image analysis tool designed to help clinicians position Percutaneous Ventricular Assist Devices (PVADs) by automatically detecting and measuring the distance between the aortic annulus and PVAD inlet in cardiac ultrasound images. It processes transthoracic echocardiography (TTE) clips from patients 18 years and older and provides clinical decision support through automated landmark detection and acceptability classification of ultrasound clips.

Technological characteristics

PVAD IQ uses deep convolutional neural networks implementing non-adaptive machine learning algorithms trained on clinical data to analyze ultrasound clips. It is substantially identical to the predicate device (LVivo Software) in its principle of operation, technology platform, algorithm type, anatomical site (heart), and scan type (vendor-neutral ultrasound). The key difference is that PVAD IQ measures distance between aortic annulus and PVAD inlet, whereas LVivo measures left ventricular ejection fraction and strain parameters.

Test standards cited

Not stated in this summary. The document references FDA Guidance documents on "Content of Premarket Submissions for Device Software Functions" and "Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions" but does not cite specific ISO, IEC, or ASTM standards.

Substantial equivalence argument

PVAD IQ is substantially equivalent to the LVivo predicate device because both share identical intended use (non-invasive ultrasound image processing), identical classification (Class II medical image management and processing system, product code QIH), identical principles of operation (machine learning-based ultrasound analysis), and identical algorithm type (deep convolutional neural networks). Although the specific measurements differ, these differences do not raise new safety or effectiveness questions, and PVAD IQ demonstrated equivalent performance through rigorous validation testing meeting pre-specified acceptance criteria.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →